Optase Ointment
Product Images NDC 72972-003

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Optase (NDC 72972-003). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Scope Health Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Purpose (Optase Hylo Night Purpose)

Purpose (Optase Hylo Night  Purpose)
A Drug Facts panel section showing the purpose of the product as an eye lubricant. The visible text includes a strength reference (.9%) and partial dosing or usage instructions related to eye irritation prevention.*
FDA Label Image

Directions (Optase Hylo Night Box Dosage)

Directions (Optase Hylo Night Box   Dosage)
A directions panel instructing to pull down the lower lid of the affected eye and apply a small amount (one-fourth inch) of ointment to the inside of the eyelid.*
FDA Label Image

Inactive (Optase Hylo Night Inactive)

Inactive (Optase Hylo Night Inactive)
Drug facts or ingredient information panel for Optase ointment showing inactive ingredients including Vitamin A palmitate and liquid paraffin. The text panel details non-active components used in the ophthalmic ointment formulation manufactured by Scope Health Inc.*
FDA Label Image

Children (Optase Hylo Night Keep Out Of Reach)

Children (Optase Hylo Night Keep Out Of Reach)
Continuation of the Drug Facts panel focusing on warnings. It advises keeping the product out of reach of children and seeking medical help or contacting a Poison Control Center immediately if swallowed.*
FDA Label Image

Pdp (Optase Hylo Night Pdp)

Pdp (Optase Hylo Night Pdp)
The packaging label for Optase Hylo Night eye ointment, a 5 g ophthalmic ointment containing vitamin A. The label highlights that the product is preservative-free and intended for ocular use. It shows the Scope brand and includes drug facts, warnings, directions, storage instructions, and a barcode. The design features blue and gray colors with a stylized eye graphic.*
FDA Label Image

Insert (Optase Hylo Night Pil 148x210 March 22th (p) Page 001)

Insert (Optase Hylo Night Pil 148x210 March 22th (p) Page 001)
Instructions for use of Optase Hylo Night, a sterile, preservative-free ophthalmic eye ointment containing white petrolatum (91.72%) and lanolin (6.9%). The text includes composition, indications for use as a lubricant to relieve eye dryness and irritation, usage guidelines, and application steps with illustrations showing how to gently pull the lower eyelid, instill the ointment without touching the eye, and close the eye afterward.*
FDA Label Image

Insert (Optase Hylo Night Pil 148x210 March 22th (p) Page 002)

Insert (Optase Hylo Night Pil 148x210 March 22th (p) Page 002)
This drug facts panel provides application recommendations, usage frequency, storage information, and warnings for OPTASE HYLO NIGHT ophthalmic eye ointment. It includes instructions on use, precautions about hypersensitivity and peanut oil content, storage temperature warnings, shelf life, and contact information for Scope Health Inc, the manufacturer. The document is dated January 2021.*
FDA Label Image

Uses (Optase Hylo Night Uses)

Uses (Optase Hylo Night Uses)
A text panel labeled "Uses" describing the purpose of the product as a lubricant to prevent further irritation or to relieve dryness of the eye.*
FDA Label Image

Warnings (Optase Hylo Night Warnings)

Warnings (Optase Hylo Night Warnings)
This image shows a warnings panel for an ophthalmic ointment. It advises use in the eyes only, instructions to avoid contamination by not touching the container tip to any surface, and to replace the cap after use. It also instructs users to stop use and consult a doctor if eye pain, changes in vision, continued redness or irritation occur, or if symptoms persist beyond 72 hours.*
FDA Label Image

Active (Optase Hylo Night Active)

Active (Optase Hylo Night Active)
Drug Facts panel showing active ingredients for an ophthalmic ointment: White Petrolatum (9%) and Lanolin (6.9%). The panel is part of the packaging for Optase ointment by Scope Health Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.